About Embecta Corp.
https://www.embecta.comEmbecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
CEO
Devdatt Kurdikar
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 184
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.19M
Value:$117.22M
BLACKROCK, INC.
Shares:8.79M
Value:$112.11M
VANGUARD GROUP INC
Shares:5.46M
Value:$69.67M
Summary
Showing Top 3 of 407
About Embecta Corp.
https://www.embecta.comEmbecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $264M ▼ | $102M ▼ | $26.4M ▼ | 10% ▼ | $0.45 ▼ | $70.8M ▼ |
| Q3-2025 | $295.5M ▲ | $103.1M ▲ | $45.5M ▲ | 15.4% ▲ | $0.78 ▲ | $110.6M ▲ |
| Q2-2025 | $259M ▼ | $101.2M ▼ | $23.5M ▲ | 9.07% ▲ | $0.4 ▲ | $74.2M ▲ |
| Q1-2025 | $261.9M ▼ | $128.4M ▼ | $-700K ▼ | -0.27% ▼ | $-0.01 ▼ | $39.1M ▲ |
| Q4-2024 | $286.1M | $147.6M | $14.6M | 5.1% | $0.25 | $34M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $225.5M ▼ | $1.09B ▼ | $1.74B ▼ | $-650.6M ▲ |
| Q3-2025 | $230.6M ▲ | $1.16B ▲ | $1.83B ▼ | $-669.6M ▲ |
| Q2-2025 | $209.3M ▼ | $1.12B ▼ | $1.86B ▼ | $-736.2M ▲ |
| Q1-2025 | $210M ▼ | $1.15B ▼ | $1.92B ▼ | $-768.8M ▼ |
| Q4-2024 | $267.5M | $1.29B | $2.02B | $-738.3M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $26.4M ▼ | $84M ▲ | $-7.3M ▼ | $-81.6M ▼ | $-5M ▼ | $76.7M ▼ |
| Q3-2025 | $45.5M ▲ | $81.2M ▲ | $-400K ▼ | $-62.6M ▼ | $21.3M ▲ | $80.8M ▲ |
| Q2-2025 | $23.5M ▲ | $31.8M ▲ | $-100K ▲ | $-37.3M ▲ | $-4.4M ▲ | $31.7M ▲ |
| Q1-2025 | $0 ▼ | $-5.3M ▼ | $-1.5M ▼ | $-45.2M ▼ | $-57.5M ▼ | $-6.8M ▼ |
| Q4-2024 | $14.6M | $26.6M | $0 | $-36.6M | $-7.6M | $26.6M |
Revenue by Products
| Product | Q2-2025 | Q4-2025 | Q3-2025 |
|---|---|---|---|
 Manufacturing Facility | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
 Product and Service Other | $0 ▲ | $10.00M ▲ | $0 ▼ |
 Safety | $30.00M ▲ | $70.00M ▲ | $30.00M ▼ |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q4-2025 | Q3-2025 |
|---|---|---|---|---|
 NonUS | $250.00M ▲ | $120.00M ▼ | $240.00M ▲ | $140.00M ▼ |
 UNITED STATES | $310.00M ▲ | $140.00M ▼ | $280.00M ▲ | $160.00M ▼ |
CEO
Devdatt Kurdikar
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 184
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:9.19M
Value:$117.22M
BLACKROCK, INC.
Shares:8.79M
Value:$112.11M
VANGUARD GROUP INC
Shares:5.46M
Value:$69.67M
Summary
Showing Top 3 of 407